Holen Sie sich die Stockscreener-App
42.25
1.83%
0.76
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.35%
34.07
|
29.29 | 27.27 | 23.74 | 20.54 |
| Operating Income/Loss |
16.35%
-34.07
|
-29.29 | -27.27 | -23.74 | -20.54 |
| Income/Loss From Continuing Operations Before Tax |
11.19%
-27.36
|
-24.60 | -22.53 | -19.23 | -19.53 |
| Income/Loss From Continuing Operations After Tax |
11.18%
-27.36
|
-24.61 | -22.53 | -19.23 | -19.53 |
|
Net Income/Loss
|
11.18%
-27.36
|
-24.61 | -22.53 | -19.23 | -19.53 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,444%
103.46
|
1.866 | 99.85 | 99.01 | 78.35 |
| Diluted Average Shares |
5,444%
103.46
|
1.866 | 99.85 | 99.01 | 78.35 |
| Basic Earnings Per Share |
4.00%
-0.26
|
-0.25 | -0.23 | -0.19 | -0.25 |
| Diluted Earnings Per Share |
4.00%
-0.26
|
-0.25 | -0.23 | -0.19 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):